title: Antidepressant-like effect of artemin in mice: a mechanism for acetyl-L-carnitine activity on depression.
abstract: BACKGROUND
  Depression may be associated with altered plasticity of the nervous system. The importance of neurotrophic factor levels is strongly suggested, and the neuronal-related family is extensively studied with respect to glial-derived one.
  
  
  OBJECTIVE
  Aimed to contribute to the study of nervous plasticity modulation as therapeutical target in mood disorders, the role of the glial-derived factor artemin (ARTN) in depression and in the pharmacodynamics of the antidepressant and trophic compound acetyl-L: -carnitine (ALCAR) was evaluated.
  
  
  METHODS
  Male mice were treated with 100 mg kg(-1) ALCAR daily for 7 days; 0.6 μg/mouse ARTN was acutely injected intracerebroventricularly. Gene knockdown of ARTN and GDNF family receptor alpha (GFRalpha3) was obtained by oligonucleotide antisense strategy. The forced swimming test was performed to evaluate antidepressant-like effects.
  
  
  RESULTS
  Repeated ALCAR administration increased ARTN levels in spinal cord, hippocampus, and prefrontal cortex. No modulatory effect was detected on BDNF and glial cell line-derived neutrotrophic factor (GDNF). ARTN, 30 min after administration, showed a dose-dependent antidepressant-like effect. ALCAR needed a 7-day treatment to reach a comparable effect; nevertheless, both substances were able to induce a phosphorylation of the GDNF family receptor Ret. A decrease of the free ARTN level by a specific ARTN antibody impaired the antidepressant-like effect of acute ARTN and repeated ALCAR. Gene knockdown of ARTN or, alternatively, of its receptor GFRalpha3 fully prevented ALCAR effectiveness.
  
  
  CONCLUSIONS
  A mechanism for the antidepressant property of ALCAR is proposed, and the novelty of the possible role of ARTN in depression is suggested.
authors: Department of Preclinical and Clinical Pharmacology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy. lorenzo.mannelli@unifi.it
authors: Lorenzo
authors: L
authors: Di Cesare Mannelli
authors: Elisa
authors: E
authors: Vivoli
authors: Alberto
authors: A
authors: Salvicchi
authors: Nicola
authors: N
authors: Schiavone
authors: Aleardo
authors: A
authors: Koverech
authors: Masa
authors: M
authors: Messano
authors: Raffaella
authors: R
authors: Nicolai
authors: Paola
authors: P
authors: Benatti
authors: Alessandro
authors: A
authors: Bartolini
authors: Carla
authors: C
authors: Ghelardini
references: Biopharm Drug Dispos. 2003 Nov;24(8):357-65
references: 14595704
references: Eur Neuropsychopharmacol. 2006 May;16(4):281-7
references: 16316746
references: Mol Psychiatry. 2000 Nov;5(6):616-32
references: 11126392
references: J Trauma Stress. 1995 Oct;8(4):527-53
references: 8564272
references: Eur Neuropsychopharmacol. 2004 Dec;14 Suppl 5:S481-90
references: 15550346
references: Trends Pharmacol Sci. 1999 Feb;20(2):59-61
references: 10101965
references: Neuropsychopharmacology. 2009 Oct;34(11):2376-89
references: 19606083
references: Biol Psychiatry. 1999 May 1;45(9):1085-98
references: 10331101
references: Neuropsychopharmacology. 2004 Jun;29(6):1105-11
references: 14970835
references: CNS Neurol Disord Drug Targets. 2007 Jun;6(3):219-33
references: 17511618
references: Exp Clin Psychopharmacol. 1997 May;5(2):107-12
references: 9234045
references: Int J Dev Neurosci. 1992 Aug;10(4):321-9
references: 1414444
references: Drugs Exp Clin Res. 1990;16(2):101-6
references: 2205455
references: Pharmacol Res. 2006 Sep;54(3):165-71
references: 16757176
references: Curr Opin Pharmacol. 2004 Feb;4(1):58-64
references: 15018840
references: Neuron. 1999 Aug;23(4):725-36
references: 10482239
references: J Neurosci. 1999 Jun 15;19(12):5034-43
references: 10366636
references: Bipolar Disord. 2002 Feb;4(1):61-6
references: 12047496
references: Biol Psychiatry. 2001 Aug 15;50(4):260-5
references: 11522260
references: Eur Psychiatry. 2008 Sep;23(6):413-20
references: 18760907
references: Trends Pharmacol Sci. 2007 Feb;28(2):68-74
references: 17218019
references: Curr Opin Pharmacol. 2007 Feb;7(1):18-21
references: 17049922
references: Cancer Res. 2000 Mar 1;60(5):1365-70
references: 10728700
references: J Neurochem. 2010 Aug;114(3):820-31
references: 20477950
references: Cell Biochem Funct. 2008 Mar-Apr;26(2):210-20
references: 17868192
references: Eur Psychiatry. 2002 Jul;17 Suppl 3:300-5
references: 15177085
references: J Psychiatr Res. 2008 Oct;42(14):1145-53
references: 18313696
references: Neuron. 1998 Dec;21(6):1291-302
references: 9883723
references: Neuropsychopharmacology. 2003 May;28(5):888-97
references: 12736633
references: Biol Psychiatry. 2006 Jun 15;59(12):1116-27
references: 16631126
references: Int J Clin Pharmacol Res. 1990;10(6):355-60
references: 2099360
references: Bioorg Med Chem. 2006 Feb 1;14(3):758-75
references: 16214350
references: Neuropsychopharmacology. 2002 Sep;27(3):410-20
references: 12225698
references: Drugs Exp Clin Res. 1987;13(7):417-23
references: 3308388
references: Prog Neuropsychopharmacol Biol Psychiatry. 1995 Jan;19(1):117-33
references: 7708926
references: Cereb Cortex. 2002 Apr;12(4):386-94
references: 11884354
references: Exp Neurol. 1993 Dec;124(2):401-12
references: 7904571
references: Brain Res Dev Brain Res. 1991 Apr 24;59(2):221-30
references: 1655307
references: Glia. 1999 Jun;26(4):291-301
references: 10383048
references: Life Sci. 1988;43(3):289-92
references: 3398700
references: Development. 2001 Oct;128(19):3685-95
references: 11585795
references: Biol Psychiatry. 2001 May 1;49(9):741-52
references: 11331082
references: Altern Med Rev. 2008 Jun;13(2):85-115
references: 18590347
references: Arch Int Pharmacodyn Ther. 1977 Oct;229(2):327-36
references: 596982
references: Neuroreport. 2010 May 12;21(7):517-21
references: 20375925
references: Psychopharmacology (Berl). 1984;83(1):1-16
references: 6429692
references: Pharmacol Res. 1995 Dec;32(6):383-9
references: 8736490
references: Neuroscience. 2010 Jun 2;167(4):1168-74
references: 20302919
references: Brain Res. 2005 Apr 18;1041(2):157-66
references: 15829225
references: Neuropharmacology. 1985 Jan;24(1):43-50
references: 2858832
references: Science. 2003 Aug 8;301(5634):805-9
references: 12907793
references: Proc Natl Acad Sci U S A. 1999 May 11;96(10):5768-73
references: 10318959
references: Biol Psychiatry. 2003 Nov 15;54(10):994-1005
references: 14625141
references: J Neurosci. 2003 Jan 1;23(1):349-57
references: 12514234
references: Neurosci Lett. 1989 Dec 15;107(1-3):251-5
references: 2616037
references: Brain Res. 1994 Jan 7;633(1-2):77-82
references: 8137174
references: Brain Res Bull. 2005 Dec 15;68(1-2):42-53
references: 16325003
references: Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):886-90
references: 18262703
references: Neuroscience. 2009 Jan 23;158(2):514-23
references: 19015003